CIK 0001314102
- Non-accelerated filer
- Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262774444
- Phone
- +1 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-05 | Liu Ye Director | Sale | −733,758 | $19.91 | $14.6M | 2,276,963 |
| 2023-12-04 | Pine Michael Craig Chief Corp Dev.&Strat. Officer | Option exercise 10b5-1 | +45,000 | $12.62 | $568K | 50,343 |
| 2023-12-04 | Pine Michael Craig Chief Corp Dev.&Strat. Officer | Sale 10b5-1 | −45,000 | $22.00 | $990K | 5,343 |
| 2023-12-04 | Pine Michael Craig Chief Corp Dev.&Strat. Officer | Sale 10b5-1 | −1,000 | $20.79 | $21K | 4,343 |
| 2023-12-04 | Pine Michael Craig Chief Corp Dev.&Strat. Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −45,000 | 55,000 | ||
| 2023-12-04 | Pine Michael Craig Chief Corp Dev.&Strat. Officer | Option exercise 10b5-1 | +45,000 | $12.62 | $568K | 50,343 |
| 2023-12-04 | Pine Michael Craig Chief Corp Dev.&Strat. Officer | Sale 10b5-1 | −45,000 | $22.00 | $990K | 5,343 |
| 2023-12-04 | Pine Michael Craig Chief Corp Dev.&Strat. Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −45,000 | 55,000 | ||
| 2023-12-04 | Paggiarino Dario A. Chief Medical Officer | Option exercise 10b5-1 | +30,625 | $10.13 | $310K | 56,332 |
| 2023-12-04 | Paggiarino Dario A. Chief Medical Officer | Sale 10b5-1 | −30,625 | $22.00 | $674K | 25,707 |
| 2023-12-04 | Paggiarino Dario A. Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −30,625 | 39,375 | ||
| 2023-12-04 | Lurker Nancy Executive Vice Chair | Sale 10b5-1 | −20,000 | $20.76 | $415K | 170,559 |
| 2023-12-04 | Cormorant Asset Management, LP 10% owner | Purchase | +321,259 | $18.80 | $6.0M | 3,852,202 |
| 2023-12-04 | Cormorant Asset Management, LP 10% owner | Purchase | +945,664 | $19.88 | $18.8M | 4,797,866 |
| 2023-12-04 | Cormorant Asset Management, LP 10% owner | Purchase | +122,625 | $20.62 | $2.5M | 4,920,491 |
| 2023-12-04 | Cormorant Asset Management, LP 10% owner | Purchase | +79,805 | $21.87 | $1.7M | 5,000,296 |
| 2023-12-04 | Cormorant Asset Management, LP 10% owner | Purchase | +28,090 | $22.80 | $640K | 5,028,386 |
| 2023-12-04 | Cormorant Asset Management, LP 10% owner | Purchase | +37,081 | $24.01 | $890K | 5,065,467 |
| 2023-12-04 | Cormorant Asset Management, LP 10% owner | Purchase | +39,899 | $24.87 | $992K | 5,105,366 |
| 2023-12-04 | Cormorant Asset Management, LP 10% owner | Purchase | +65,086 | $25.88 | $1.7M | 5,170,452 |
Page 20 of 31 · 616 trades